Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
CNS Drugs|November 22, 2022
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysisAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
The Lancet. Neurology|January 22, 2019
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialPeter A LeWitt, Robert A Hauser, Rajesh Pahwa, et al.
Movement Disorders Clinical Practice|April 18, 2023
Expert Consensus on the Use of <i>On</i>-Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi PanelStuart H Isaacson, Madhureeta Achari, Roongroj Bhidayasiri, et al.
Clinical Parkinsonism & Related Disorders|April 22, 2026
Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON studyOlga Klepitskaya, Peter A LeWitt, Camilla Kilbane, et al.
JAMA Neurology|August 14, 2023
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical TrialRobert A Hauser, Alberto J Espay, Aaron L Ellenbogen, et al.
Clinical Neuropharmacology|October 27, 2009
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effectsKelly E Lyons, Joseph H Friedman, Neal Hermanowicz, et al.
JAMA Neurology|October 20, 2025
Transcutaneous Peripheral Nerve Stimulation for Essential Tremor: A Randomized Clinical TrialWilliam G Ondo, Wen Lv, Xiaodong Zhu, et al.
Archives of Neurology|March 10, 2010
Increased melanoma risk in Parkinson disease: a prospective clinicopathological studyJohn M Bertoni, John Philip Arlette, Hubert H Fernandez, et al.
JAMA Neurology|March 20, 2026
Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical TrialHubert H Fernandez, Stuart H Isaacson, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
Pageof 9